Highlights from the Manifesto on the Health Economics of Cardiovascular Disease Prevention

Zanfina Ademi (), Sheridan E. Rodda, Karl Vivoda, Susan Hennessy, Olive Fenton and James S. Ware
Additional contact information
Zanfina Ademi: Monash University
Sheridan E. Rodda: Monash University
Karl Vivoda: Monash University
Susan Hennessy: University of California
Olive Fenton: Global Heart Hub
James S. Ware: National Heart and Lung Institute, Imperial College London

PharmacoEconomics, 2025, vol. 43, issue 11, No 3, 1292 pages

Abstract: Abstract Cardiovascular disease (CVD) is a major contributor to the health and economic burden of disease globally. In this paper we discuss the literature on the health economics of the prevention and early intervention in CVD. We reveal the large economic impact of CVD and provide the economic argument supporting the calls for early detection and diagnosis of CVD outlined in the Global Heart Hub’s patient-led Manifesto for Change. Many challenges in conducting cost-effectiveness analyses of interventions for CVD prevention are identified, as well as the emerging statistical and economic methods to help overcome these issues. Lastly, we acknowledge the profound disparities in cardiovascular health faced by minority or underserved populations, and the important role that prevention and early intervention can play in improving health equity.

Date: 2025
References: Add references at CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s40273-025-01537-5 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:pharme:v:43:y:2025:i:11:d:10.1007_s40273-025-01537-5

Ordering information: This journal article can be ordered from
http://www.springer.com/economics/journal/40273

DOI: 10.1007/s40273-025-01537-5

Access Statistics for this article

PharmacoEconomics is currently edited by Timothy Wrightson and Christopher I. Carswell

More articles in PharmacoEconomics from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().